UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities and Exchange Act of 1934
Date of Report (Date of earliest event reported): April 30, 2005
--------------
IN VERITAS MEDICAL DIAGNOSTICS, INC.
---------------------------------------------------
(Exact name of registrant as specified in charter)
Colorado 000-49972 84-15719760
----------------------------- ---------------- ------------------
(State or other jurisdiction (Commission File (IRS Employer
of incorporation) Number) Identification No.)
The Green House, Beechwood Business Park, North, Inverness, Scotland IV2 3BL
------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: 011-44-1463-667347
------------------
Copies to:
Richard A. Friedman, Esq.
Sichenzia Ross Friedman Ference LLP
1065 Avenue of the Americas, 21st Floor
New York, New York 10018
(212) 930-9700
(212) 930-9725 (fax)
-------------------------------------------
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instructions A.2. below):
/_/ Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
/_/ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
/_/ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
/_/ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
Section 5 Corporate Governance and Management
Item 5.02 Departure of Directors or Principal Officers; Election of Directors;
Appointment of Principal Officers
On April 30, 2005, Martin E. Thorp, 53 years old, was appointed as a Director of
the Company.
From 2002 through 2005, Mr. Thorp had been involved in various entrepreneurial
activities including, the establishment of Biz-Bud Ltd., a private company which
provides outsourcing solutions for the small and mid-sized enterprises ("SMEs")
across the entire business support spectrum; developing a consulting capability
for SMEs; acting as a consultant to an international corporate finance and
strategic advisory boutique; serving as strategic advisory non-executive board
member of Grant Thornton; and serving in various short term consulting and
interim management positions. From 1996 to 2002, Mr. Thorp served as Global
Managing Partner, Corporate Finance for Arthur Andersen, London and New York.
Mr. Thorp graduated with first class honors from the University of Kent at
Canterbury (UK) in Accounting and Business Finance. Mr. Thorp is a Fellow of the
Institute of Chartered Accountants in England and Wales and a member of the
Securities Institute (in the UK).
Item 9.01 Financial Statements and Exhibits.
(a) Financial statements of business acquired.
Not applicable.
(b) Pro forma financial information.
Not applicable.
(c) Exhibits
None.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
IN VERITAS MEDICAL DIAGNOSTICS, INC.
Date: August 4, 2005 /s/ John Fuller
-------------------------------------
John Fuller
President and Chief Executive Officer
End of Filing